INSIGHTS ON CLINICAL TRIAL DESIGN
-
A Community-Focused Approach To Metabolic Disease Trials
Learn how innovative strategies like free health exams, community engagement, and a comprehensive patient database helped this project achieve rapid enrollment with a high level of patient diversity.
-
Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy
Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.
-
The Scoop On The SCOPE Summit
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch
Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
-
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials3/12/2026
Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
FDA Draft Guidance On Diversity Action Plan Requirements10/24/2024
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Rare Disease R&D: Continued Growth Amid Challenges3/21/2025
The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.
-
Scout's Science-Based Targets Commitment: What Comes Next1/14/2026
Explore the latest Science Based Targets initiative commitment, clarifying what has been approved, what remains in progress, and the steps required before emissions reduction targets can be validated.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
-
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
-
Learn about a unified ecosystem integrating eConsent, IRT, eCOA, and ePatient into a seamless workstream designed with a patient-centric approach.